Assertio Holdings, Inc. (ASRT)
Jun 16, 2026 - ASRT was delisted (reason: merged with Zydus Lifesciences)
23.50
+0.02 (0.09%)
Inactive · Last trade price on Jun 15, 2026
Assertio Holdings Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 33.71 | 10.23 | 50.59 | 73.44 | 64.94 | 36.81 |
Short-Term Investments | 37.86 | 53.18 | 49.47 | - | - | - |
Cash & Short-Term Investments | 71.57 | 63.41 | 100.05 | 73.44 | 64.94 | 36.81 |
Cash Growth | -18.04% | -36.63% | 36.24% | 13.09% | 76.42% | 77.09% |
Accounts Receivable | 61.53 | 120.11 | 54.12 | 47.66 | 45.36 | 44.36 |
Inventory | 23.01 | 24.12 | 38.31 | 37.69 | 13.7 | 7.49 |
Other Current Assets | 10.75 | 9.01 | 10.07 | 12.27 | 8.27 | 14.84 |
Total Current Assets | 166.86 | 216.65 | 202.55 | 171.06 | 132.26 | 103.5 |
Net Property, Plant & Equipment | 0.41 | 0.44 | 0.59 | 0.77 | 0.74 | 1.53 |
Other Intangible Assets | 43.1 | 48.91 | 80.47 | 111.33 | 198 | 216.05 |
Other Long-Term Assets | 0.93 | 0.97 | 1.13 | 3.26 | 82.91 | 5.47 |
Total Assets | 211.3 | 266.97 | 284.73 | 286.42 | 413.91 | 326.55 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 5.91 | 9.01 | 14.74 | 13.44 | 5.99 | 6.69 |
Accrued Expenses | 80.83 | 113.65 | 95.15 | 76.35 | 61.61 | 67.36 |
Current Portion of Long-Term Debt | - | - | - | - | 0.47 | 12.17 |
Other Current Liabilities | 4.83 | 4.85 | 4.8 | 3.65 | 27.25 | 48.8 |
Total Current Liabilities | 91.57 | 127.51 | 114.69 | 93.44 | 95.32 | 135.02 |
Long-Term Debt | 39.25 | 39.12 | 38.81 | 38.51 | 66.4 | 61.32 |
Other Long-Term Liabilities | 4.85 | 6.38 | 10.15 | 16.46 | 26.47 | 27.8 |
Total Long-Term Liabilities | 44.09 | 45.51 | 48.96 | 54.97 | 92.87 | 89.11 |
Total Liabilities | 135.67 | 173.02 | 163.65 | 148.42 | 188.19 | 224.13 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0 | 0 | 0 | 0.01 | 0.01 | 0 |
Additional Paid-in Capital | 797.99 | 797.45 | 794.2 | 789.54 | 545.32 | 531.64 |
Retained Earnings | -722.36 | -703.5 | -673.12 | -651.54 | -319.6 | -429.23 |
Shareholders' Equity | 75.63 | 93.95 | 121.08 | 138 | 225.73 | 102.41 |
Total Liabilities & Equity | 211.3 | 266.97 | 284.73 | 286.42 | 413.91 | 326.55 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 39.25 | 39.12 | 38.81 | 38.51 | 66.87 | 73.49 |
Net Cash (Debt) | 32.32 | 24.28 | 61.24 | 34.93 | -1.93 | -36.68 |
Net Cash Growth | -33.22% | -60.35% | 75.34% | - | - | - |
Net Cash Per Share | 4.91 | 3.79 | 9.64 | 7.38 | -0.53 | -12.75 |
Book Value | 75.63 | 93.95 | 121.08 | 138 | 225.73 | 102.41 |
Book Value Per Share | 11.48 | 14.67 | 19.06 | 29.14 | 61.93 | 35.59 |
Tangible Book Value | 32.53 | 45.04 | 40.61 | 26.67 | 27.73 | -113.64 |
Tangible Book Value Per Share | 4.94 | 7.03 | 6.39 | 5.63 | 7.61 | -39.49 |